FDA Approves First Oral Somatostatin Analog for Acromegaly FDA Approves First Oral Somatostatin Analog for Acromegaly

The oral drug octreotide offers an alternative to long-term injections for the rare chronic disease.FDA Approvals
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news